IMPACT: A Randomized WOO Study of Novel Therapeutic Agents in Women Triaged to Primary Surgery for EOC
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
Clinical Trials Related to Ovarian Cancer
Related studies linked through entity extraction aliases.
Cytoreductive Surgery(CRS) Plus Hyperthermic Intraperitoneal Chemotherapy(HIPEC) With Lobaplatin in Advanced and Recurrent Epithelial Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE3
The Treatment Preferences of Women Diagnosed With Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Real-World Effectiveness of Bevacizumab Based on AURELIA in Platinum-resistant Recurrent Ovarian Cancer
- Status
- COMPLETED
- Phase
- N/A
Stepping Into Survivorship: Harnessing Behavioral Economics to Improve Quality of Life in Ovarian Cancer
- Status
- COMPLETED
- Phase
- NA
BEACON - ABC in Recurrent Platinum Resistant HGSOC
- Status
- UNKNOWN
- Phase
- PHASE2
Engineered Immune Effectors Against Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
BrUOG 354 Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Study of the Safety, Pharmacokinetics and Efficacy of Tinostamustine in Patients With Advanced Solid Tumors.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Combination of Nivolumab and Ipilimumab in Breast, Ovarian and Gastric Cancer Patients
- Status
- TERMINATED
- Phase
- PHASE2
Study of Fludarabine With Pegylated Liposomal Doxorubicin Versus Pegylated Liposomal Doxorubicin Alone In Patients With Platinum Resistant/Refractory Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Genetic Risk Assessment for Cancer Education and Empowerment (GRACE) Project
- Status
- COMPLETED
- Phase
- NA
Dose Escalation and Efficacy Study of mRNA-2416 for Intratumoral Injection Alone and in Combination With Durvalumab for Participants With Advanced Malignancies
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Heated Intraperitoneal Chemotherapy in Primary Ovarian Cancer Patients
- Status
- UNKNOWN
- Phase
- PHASE2
A Phase 1/2 Study of INCB001158 in Combination With Chemotherapy in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ability of a Dendritic Cell Vaccine to Immunize Melanoma or Epithelial Cancer Patients Against Defined Mutated Neoantigens Expressed by the Autologous Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Apatinib Plus Etoposide Versus Etoposide Alone for Platinum-resistant Recurrent Ovarian Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
ROCKIF Trial: Re-sensitization of Carboplatin-resistant Ovarian Cancer With Kinase Inhibition of FAK
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
VM110 in Detection of Microscopic Tumors: A Phase I Study
- Status
- TERMINATED
- Phase
- PHASE1